Supernus Pharmaceuticals Inc.

Neurology

Clinical research activity is centered on epilepsy, with a specific focus on focal onset seizures in adults. The sponsor’s trial portfolio reflects interest in seizure control and the treatment of neurologic disorders that affect daily functioning and safety.

  • Focal onset seizures
  • Adult epilepsy
  • Seizure management

Research efforts are directed toward therapeutic options for adults living with recurrent seizure activity and related neurologic symptoms.

Antiseizure Therapy

The sponsor’s clinical interest includes antiseizure medications designed to address seizure frequency and disease burden in central nervous system disorders. Its research landscape is aligned with treatment development for patients whose seizures remain a significant clinical concern.

  • Antiseizure treatment
  • Central nervous system disorders
  • Adult seizure disorders

Work in this area supports therapeutic development for neurologic conditions requiring long-term seizure control.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study of SPN-817 (Huperzine A) in Adults with Focal Onset Seizures: Testing Safety and Effectiveness of Treatment

    Not yet recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Hungary Poland